NCT04145115 2026-05-29A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational BurdenNational Cancer Institute (NCI)Phase 2 Active not recruiting37 enrolled